Sphingolipids and Atherosclerosis
- 6 August 2026
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 28 (1) , 76
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health (RO1, HL149730)
This publication has 150 references indexed in Scilit:
- Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health StudyJAMA Network Open, 2023
- Sphingomyelin Synthase Family and Phospholipase Cs2022
- Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence TomographyJournal of Cardiovascular Translational Research, 2020
- The regulatory roles of glycosphingolipid‐enriched lipid rafts in immune systemsFEBS Letters, 2018
- Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtypeDiabetologia, 2013
- Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: Evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproductionAtherosclerosis, 2013
- Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery diseaseBasic Research in Cardiology, 2010
- Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and PathophysiologyToxicology and Applied Pharmacology, 1997
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992
- Neutral glycosphingolipid content and composition of cells from normal and atherosclerotic human aortaAtherosclerosis, 1992